Analyst Research

Report Title Price
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TherapeuticsMD Inc positive results of rabbit irritation study for its estradiol vaginal capsule vagicap for treatment of vulvar vaginal atrophy

Monday, 7 Apr 2014 04:05pm EDT 

TherapeuticsMD Inc:Says positive outcomes of a rabbit irritation study for TX 004-HR (formerly referred to as TX 12-004-HR), a rapidly acting estrogen vaginal preparation capsule (VagiCap).This toxicity study involved vaginal administration of VagiCap in New Zealand white female rabbits. The study demonstrated that TX 004-HR was non-irritant following a 28-day repeated application to the vaginal mucosa. 

Company Quote

0.15 +3.44%
19 Dec 2014